H.C. Wainwright reiterated coverage on Eton Pharmaceuticals with a new price target
$ETON
Biotechnology: Pharmaceutical Preparations
Health Care
H.C. Wainwright reiterated coverage of Eton Pharmaceuticals with a rating of Buy and set a new price target of $33.00 from $17.00 previously